TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,857,363 | -27.5% | 2,016,431 | +115.3% | 0.01% | -18.2% |
| Q2 2023 | $23,263,405 | +54537.1% | 936,530 | -66.9% | 0.01% | -56.0% |
| Q1 2023 | $42,578 | -49.9% | 2,830,973 | -60.6% | 0.02% | -47.9% |
| Q4 2022 | $84,924 | -99.7% | 7,178,672 | +72.5% | 0.05% | +220.0% |
| Q3 2022 | $24,640,000 | +4.0% | 4,162,197 | -25.4% | 0.02% | +7.1% |
| Q2 2022 | $23,697,000 | -3.3% | 5,575,652 | +116.4% | 0.01% | 0.0% |
| Q1 2022 | $24,504,000 | +108.3% | 2,576,649 | +316.2% | 0.01% | +133.3% |
| Q4 2021 | $11,762,000 | +512.0% | 619,091 | +971.9% | 0.01% | +500.0% |
| Q3 2021 | $1,922,000 | -58.4% | 57,758 | -51.6% | 0.00% | -66.7% |
| Q2 2021 | $4,624,000 | -69.7% | 119,214 | -62.3% | 0.00% | -72.7% |
| Q1 2021 | $15,254,000 | -46.2% | 316,471 | -41.9% | 0.01% | -45.0% |
| Q4 2020 | $28,329,000 | +55.1% | 544,576 | -20.2% | 0.02% | -13.0% |
| Q3 2020 | $18,261,000 | -32.4% | 682,390 | -50.8% | 0.02% | -37.8% |
| Q2 2020 | $27,008,000 | +131.7% | 1,386,459 | +17.0% | 0.04% | +42.3% |
| Q1 2020 | $11,657,000 | -71.4% | 1,184,641 | -67.7% | 0.03% | -49.0% |
| Q4 2019 | $40,737,000 | -3.5% | 3,670,043 | -51.2% | 0.05% | -23.9% |
| Q3 2019 | $42,235,000 | -8.9% | 7,521,910 | +40.3% | 0.07% | -4.3% |
| Q2 2019 | $46,363,000 | -14.4% | 5,359,859 | -20.5% | 0.07% | -13.6% |
| Q1 2019 | $54,174,000 | +10955.9% | 6,737,986 | +5533.2% | 0.08% | +8000.0% |
| Q4 2018 | $490,000 | -68.9% | 119,611 | -57.5% | 0.00% | -50.0% |
| Q3 2018 | $1,575,000 | -77.2% | 281,315 | -46.5% | 0.00% | -77.8% |
| Q2 2018 | $6,911,000 | +24.8% | 525,552 | +34.8% | 0.01% | +28.6% |
| Q1 2018 | $5,538,000 | +253.0% | 389,990 | +194.6% | 0.01% | +250.0% |
| Q3 2017 | $1,569,000 | +317.3% | 132,401 | +254.3% | 0.00% | +100.0% |
| Q2 2017 | $376,000 | -83.1% | 37,374 | -80.4% | 0.00% | -75.0% |
| Q1 2017 | $2,221,000 | +227.6% | 190,627 | +30.8% | 0.00% | +300.0% |
| Q4 2016 | $678,000 | -43.6% | 145,726 | -26.5% | 0.00% | -66.7% |
| Q2 2016 | $1,202,000 | -36.3% | 198,298 | +25.4% | 0.00% | -25.0% |
| Q4 2015 | $1,886,000 | +238.6% | 158,125 | +370.8% | 0.00% | +300.0% |
| Q2 2015 | $557,000 | -47.1% | 33,587 | -50.6% | 0.00% | -50.0% |
| Q1 2015 | $1,052,000 | -27.9% | 67,977 | -50.3% | 0.00% | -50.0% |
| Q3 2014 | $1,460,000 | -42.6% | 136,877 | -49.4% | 0.00% | -42.9% |
| Q2 2014 | $2,542,000 | +197.0% | 270,722 | +59.5% | 0.01% | +133.3% |
| Q3 2013 | $856,000 | – | 169,749 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |